Literature DB >> 34169345

Associations between bone mineral density in different measurement locations and coronary artery disease: a cross-sectional study.

Yaoling Wang1, Ruiyun Wang1, Yun Liu1, Lijuan Bai1, Lihua Liu1, Linfeng He1, Heng Deng1, Tao Li1, Sha Xu1, Li Chen2, Kai Wen3, Benling Qi4.   

Abstract

The bone mineral density (BMD) loss is closely related to coronary heart disease (CAD). The BMD measured at different locations differ in BMD values, the risk to CAD, and the capability to identify CAD. An average BMD of the right and left femoral neck being below - 1.70 has the ability to indicate risk of CAD.
PURPOSE: Previous studies have reported that low bone mineral density (BMD) is closely related to coronary artery disease (CAD); however, it is not clear that the BMD loss at which location to what extent has the greatest effect in identifying risk of CAD. This study aimed to evaluate the ability of different measurement sites of BMD in identifying CAD and analyze the best measurement sites and the optimal cut-off of BMD for CAD.
METHODS: This was a cross-sectional study in which 180 of 817 participants were diagnosed with CAD. All participants in the study were measured by dual-energy X-ray absorptiometry (DEXA) for BMD at 8 locations, and following measurements were derived: the average BMD of lumbar spine (L1-L4), femoral neck (left and right), and total proximal femur (left and right). The association between BMD at different locations and CAD was analyzed using logistic regression. The receiver operating characteristic (ROC) curve was used to select the optimal measurement location and cut-off value of the BMD for identifying CAD.
RESULTS: There were significant differences in BMD at 3 different measurement locations. Higher BMD is a protective factor against CAD, which is more pronounced in the femoral neck and total proximal femur (ORs = 0.47 ~ 0.66, P < 0.001) than in the lumbar spine (ORs = 0.74 ~ 0.79, P < 0.001). The optimal site for predicting the risk of CAD by BMD is the femoral neck, with the AUC (area under the ROC curve) is 0.72 (95% CI: 0.67 ~ 0.76) and the cut-off is - 1.70.
CONCLUSION: The BMD below particular cut-off of the femoral neck rather than of the lumbar spine may have certain further research value for revealing the risk of CAD.

Entities:  

Keywords:  Bone mineral density; Coronary artery disease; Dual-energy X-ray absorptiometry; Measurement location

Mesh:

Year:  2021        PMID: 34169345     DOI: 10.1007/s11657-021-00940-7

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  41 in total

1.  Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification.

Authors:  Kerry L Tyson; Joanne L Reynolds; Rosamund McNair; Qiuping Zhang; Peter L Weissberg; Catherine M Shanahan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-30       Impact factor: 8.311

2.  Correlation between osteocalcin-positive endothelial progenitor cells and spotty calcification in patients with coronary artery disease.

Authors:  He Zhang; Li-jun Wang; Dong-lei Si; Chuan Wang; Jing-ci Yang; Ping Jiang; Chao Du; Jian-jun Wang
Journal:  Clin Exp Pharmacol Physiol       Date:  2015-07       Impact factor: 2.557

3.  Relationship between bone mineral density and a 10-year risk for coronary artery disease in a healthy Korean population: the Korea National Health and Nutrition Examination Survey 2008-2010.

Authors:  Hyung Tak Lee; Jinho Shin; Seung Yeon Min; Young-Hyo Lim; Kyung-Soo Kim; Soon Gil Kim; Jeong Hyun Kim; Heon Kil Lim
Journal:  Coron Artery Dis       Date:  2015-01       Impact factor: 1.439

4.  A community-based study of the relationship between coronary artery disease and osteoporosis in Chinese postmenopausal women.

Authors:  Najia Liu; Jun Chen; Keqin Zhang; Zihui Tang
Journal:  Coron Artery Dis       Date:  2016-01       Impact factor: 1.439

5.  Usefulness of bone mineral density to predict significant coronary artery disease.

Authors:  Pamela A Marcovitz; Hillary H Tran; Barry A Franklin; William W O'Neill; Michael Yerkey; Judith Boura; Michael Kleerekoper; Christine Z Dickinson
Journal:  Am J Cardiol       Date:  2005-08-22       Impact factor: 2.778

6.  The link between osteoporosis and cardiovascular disease.

Authors:  Ghada N Farhat; Jane A Cauley
Journal:  Clin Cases Miner Bone Metab       Date:  2008-01

Review 7.  Osteoporosis and ischemic cardiovascular disease.

Authors:  Michel Laroche; Virginie Pécourneau; Hubert Blain; Véronique Breuil; Roland Chapurlat; Bernard Cortet; Bruno Sutter; Yannick Degboe
Journal:  Joint Bone Spine       Date:  2016-11-09       Impact factor: 4.929

8.  Decreased bone mineral density is correlated with increased subclinical atherosclerosis in older, but not younger, Mexican American women and men: the San Antonio Family Osteoporosis Study.

Authors:  John R Shaffer; Candace M Kammerer; David L Rainwater; Daniel H O'Leary; Jan M Bruder; Richard L Bauer; Braxton D Mitchell
Journal:  Calcif Tissue Int       Date:  2007-11-09       Impact factor: 4.333

9.  Osteoprotegerin and mortality in type 2 diabetic patients.

Authors:  Henrik Reinhard; Maria Lajer; Mari-Anne Gall; Lise Tarnow; Hans-Henrik Parving; Lars M Rasmussen; Peter Rossing
Journal:  Diabetes Care       Date:  2010-10-07       Impact factor: 19.112

10.  Relationship between circulating serum osteoprotegerin and total receptor activator of nuclear κ-B ligand levels, triglycerides, and coronary calcification in postmenopausal women.

Authors:  Indu G Poornima; Rachel H Mackey; Alhaji M Buhari; Jane A Cauley; Karen A Matthews; Lewis H Kuller
Journal:  Menopause       Date:  2014-07       Impact factor: 2.953

View more
  1 in total

Review 1.  Insights Into the Role of Mitochondria in Vascular Calcification.

Authors:  Z L Zeng; Qing Yuan; Xuyu Zu; Jianghua Liu
Journal:  Front Cardiovasc Med       Date:  2022-04-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.